Acrongenomics Appoints President and Vice President
News Feb 16, 2006
Acrongenomics, Inc. has announced the appointment of Mr. Constantine Poulios, LL.M., as President. Mr. Poulios was holding the position of Vice President at Acrongenomics Inc. as of July 6, 2004.
Mr. Poulios succeeds Dr. Eleftherios Georgakopoulos, who retired from the board earlier this week.
The leadership change coincides with the transfer of the former president's 4 million shares to the treasury of the company, while the company keeps full title on all its technology developed to date.
Mr. Poulios has extensive experience in serving multinational companies. An attorney by education and profession, he was part of the Corporate and Tax Advisory Services of Ernst & Young before joining Acrongenomics, Inc.
Mr. Poulios was managing important accounts including that of Coca Cola, Halliburton, Hewlett Packard, ABN AMRO, Citigroup, Ciments Francais, Pfizer, GlaxoSmithKline and EMI Music for Ernst & Young Southeast Europe, while he has also worked for Ernst & Young in the US.
Mr. Poulios has also been awarded with a Certificate in Law in 1993 from the School of Law at the University of Bordeaux in France and he has attended graduate courses in management in US universities.
As a corporate executive who has driven business initiative of global corporations for some years, Mr. Poulios is looking forward to bringing in apart from his skills and his business and legal expertise, hands-on knowledge on how to properly conduct business in the rigorous environment of the Sarbanes-Oxley legislation.
Acrongenomics, Inc. has also announced the appointment of Mr. Platon Tzouvalis, MSc. as Vice President.
As a Biochemist, Mr. Tzouvalis is an experienced pharmaceutical industry professional. He has been a member of Acrongenomics' Scientific Advisory Board since May 2004.
His expertise lies in the areas of Quality Control, Operational Procedures as well as Pharmaceutical Product and Process Improvement.
Mr. Tzouvalis' earlier career includes working as a Research Chemist in collaboration with the University of Illinois at Chicago, holding the position of Research and Development Chemist at SynQuest, Inc. and as Advanced Quality Assurance Specialist of Organic Operations and then Project Manager in Bioanalytical Quality Assurance for Abbott Laboratories.
Mr. Tzouvalis has also been awarded with the Abbott Diagnostics Division Science Award of 2002 as part of the Organic Operation Remediation Team.
New Areas of the Brain Become Active After Students Learn PhysicsNews
Parts of the brain not traditionally associated with learning science become active when people are confronted with solving physics problems.READ MORE
Diamonds Could Decrease Cost of Imaging and Spectroscopy DevicesNews
A new approach shows great promise for enhancing the signal from magnetic resonance imaging (MRI) and nuclear magnetic resonance (NMR) using lasers without expensive magnets.
Schizophrenics' Blood Contains RNA From More MicrobesNews
The blood of schizophrenia patients features genetic material from more types of microorganisms than that of people without the debilitating mental illness, research at Oregon State University has found. What’s not known is whether that’s a cause or effect of the severe, chronic condition that strikes about one person in 100.READ MORE